FUJIFILM Diosynth Biotechnologies Newsletter - February 2024

Latest News

FUJIFILM Diosynth Biotechnologies and SHL Medical Enter strategic partnership agreement to help meet growing market demand for autoinjector medicines?

We announced the expansion of our finished goods autoinjector services in Denmark with the addition of SHL Medical’s Molly? autoinjector platform.

Fujifilm to Invest USD 200 Million to Expand

The Fujifilm Corporation announced the investment of USD 200 million in two subsidiaries to significantly expand global cell therapy contract development and manufacturing (CDMO) capabilities.

Watch Our Holly Springs Site Unveiling Video

We are excited to share the progress of our Holly Springs site. The monumental achievements to date signify an important milestone for our team toward our 2025 grand opening.

Insights from our 2023 Lunch and Learns

Throughout 2023, we continued hosting our informative series of Lunch and Learns. Held at our Cambridge Collaboration Center (C3) in Cambridge, MA, these events are dedicated to sharing industry-specific scientific topics and best practices while fostering collaboration with colleagues.

Subject matter experts from across our?FDB global network?spoke at these events, sharing valuable insights on topics including the development of gene therapies for rare diseases, process characterization, and strategies for a diverse mAb pipeline. In case you missed any of our 2023 sessions, here is a recap of the highlights and links to the recordings.

Keep an eye on our LinkedIn page for updates on our 2024 Lunch and Learns.

Thought Leadership

Navigating the Allogeneic Commercialization Journey: The Challenges and Triumphs

We walk through the journey?towards preparing a GMP facility for an allogeneic cell therapy product’s commercialization, highlighting the pivotal moments that have shaped our evolution from facility construction to a fully operational, patient-focused CDMO.

Prioritize Your Finished Goods Experience to Bring Medicine to Patients Safely

Amid the race to deliver a best-in-class therapeutic to patients, we discuss the impact of working with an end-to-end manufacturer that offers drug substance, drug product and finished goods manufacturing, with the technology to accommodate your need for a variety of finished good container formats.

Experience Matters: Developing and Commercializing Efficient and Effective PEGylation Processes

This white paper outlines our extensive experience in navigating our customers through development challenges for PEGylated microbial therapeutics, and shares our perspectives on the future of conjugation and PEGylation in biologics.

Upcoming Events?

Join us for these virtual events in collaboration with Life Science Connect:

In the Future of Medicine – Expanding Cell Therapy Capacity?

February 15, 10 am EST

This talk will showcase examples of flexibility and state-of-the-art designs to ensure that every cell therapy program, no matter where it is on the journey from discovery to marketing authorization, can be produced at FUJIFILM Diosynth Biotechnologies California. By investing in cell therapy services,?we are committed to improving the lives of more patients through a true partnership mindset with our customers.

Accelerating Rare Disease Therapies: What Can any CDMO Offer?

February 29, 11 am EST

COVID vaccine development went from gene to trials, then on to mass vaccination at a rapid pace. To enable curative therapies for rare diseases to reach patients more rapidly, CDMOs can streamline workflows, internalize critical reagents, standardize facilities and equipment.?These, together with understanding the design space to create robust manufacturing processes with supporting analytics, are key to advancing these therapies.?

We are attending DCAT Week 2024

March 18-21, New York City, NY

DCAT Week is a multifaceted event where Member Companies have the opportunity to reserve meeting space through the DCAT organization to conduct high-level, private, strategic meetings with customers and suppliers. Members can attend various networking events, access member lounges, and take advantage of other opportunities designed to promote interaction between industry colleagues. FUJIFILM Diosynth Biotechnologies will have a meeting space in the Lotte NY Palace. Request a meeting in advance.